PTC Therapeutics | PTCT - Market Capitalization


PTC Therapeutics reported $5.4B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 3.6B 10M Sep/2025
Alnylam Pharmaceuticals USD 39.74B 12.8B Feb/2026
Amgen USD 201.45B 25.2B Feb/2026
BioCryst Pharmaceuticals USD 1.23B 115M Dec/2023
Biogen USD 27.01B 1.19B Feb/2026
BioMarin Pharmaceutical USD 11.99B 575M Feb/2026
Cytokinetics USD 8.06B 1.49B Feb/2026
Daiichi Sankyo JPY 6.34T 62.51B Dec/2025
Enanta Pharmaceuticals USD 198M 37M Dec/2023
Esperion Therapeutics USD 340M 235M Dec/2023
Gilead Sciences USD 183.59B 31.31B Feb/2026
Incyte USD 22.7B 3.31B Feb/2026
Ionis Pharmaceuticals USD 10.43B 4.14B Sep/2025
Ironwood Pharmaceuticals USD 213M 97M Sep/2025
Novartis USD 265.66B 9.48B Sep/2025
Pfizer USD 152.89B 11.32B Feb/2026
PTC Therapeutics USD 5.36B 744M Feb/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
Sarepta Therapeutics USD 2.02B 336M Sep/2025
TG Therapeutics USD 5.74B 21M Sep/2025
Ultragenyx Pharmaceutical USD 1.94B 284M Feb/2026
Vertex Pharmaceuticals USD 120.12B 5.09B Feb/2026
Xencor USD 837M 278M Sep/2025